Financings of the Fortnight is here to point you toward START-UP ’s newly published 2012 A-List, but first let’s note some big numbers. U.S. listed biotechs raised at least $1.8 billion in stock a
As executives and investors scramble to find business models that more closely link investment and return, a handful of technology firms have alit on variations of a capital-efficient strategy: let so